Jun H, Tanaka Y, Johri S, et al. A context-augmented large language model for accurate precision oncology medicine recommendations. Cancer cell. 2026. doi:10.1016/j.ccell.2025.12.017
Cancer Program
Martin-Alonso C, Alamdari S, Samad TS, Yang KK, Bhatia SN, Amini AP. Deep learning guided design of protease substrates. Nature communications. 2026;17(1):54. doi:10.1038/s41467-025-67226-1
Pimenta EM, Garza AE, Camp SY, et al. Epigenetic dysregulation of metabolic programs mediates liposarcoma cell plasticity. Science translational medicine. 2026;18(833):eadw4689. doi:10.1126/scitranslmed.adw4689
Abbott KL, Subudhi S, Ferreira R, et al. Nutrient requirements of organ-specific metastasis in breast cancer. Nature. 2026. doi:10.1038/s41586-025-09898-9
Pilcher WC, Yao L, Gonzalez-Kozlova E, et al. A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma. Nature cancer. 2026. doi:10.1038/s43018-025-01072-4
Zhong S, Wu B, Dubois F, et al. Genomic landscape and immunological profile of glioblastoma in East Asian patients. Cell reports. Medicine. 2025;6(8):102217. doi:10.1016/j.xcrm.2025.102217
Apfelbaum AA, Morin E, Sturm D, et al. A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas. Nature communications. 2025;16(1):7018. doi:10.1038/s41467-025-61820-z
Knudsen NH, Escobar G, Korell F, et al. In vivo CRISPR screens identify modifiers of CAR T cell function in myeloma. Nature. 2025. doi:10.1038/s41586-025-09489-8
Yang J, Wang C, Fu D, et al. Mature and migratory dendritic cells promote immune infiltration and response to anti-PD-1 checkpoint blockade in metastatic melanoma. Nature communications. 2025;16(1):8151. doi:10.1038/s41467-025-62878-5
Guo JA, Gong D, Evans K, et al. Integrative genomic identification of therapeutic targets for pancreatic cancer. Cell reports. 2025;44(9):116191. doi:10.1016/j.celrep.2025.116191